Navigation Links
Researchers control growth rate of replacement blood vessels, tissues
Date:3/6/2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)... COLUMBIA, S.C., Nov. 21 /PRNewswire-USNewswire/ -...mmittee for Quality Assurance (NCQA) ranked BlueCh...ird of America,s Best Health Plans(TM), published ... , , The respected annual ranking ranks the...ity, member satisfaction and NCQA accreditation sc...
(Date:11/21/2008)... FRANKLIN LAKES, N.J., Nov. 21 /PRNewswire-FirstCa...ice for medical intervention in treating 88 percen...0 percent of Americans treated for a chronic condi...ug spending and 75 percent of all medical costs. ...ree years by Medco Health Solutions, Inc. (NYSE: ...
(Date:11/21/2008)... Study found 2 popular drugs do not cause genetic ...AY, Nov. 21 (HealthDay News) -- Two popular medica... disorder (ADHD) do not cause genetic damage linke...w study says. , The study, done by researchers ... Institutes of Health, counters a previous one tha...
(Date:11/21/2008)..., In 430 B.C., a new and deadly diseaseits cause ...ek city-state was teeming with citizens, soldiers ... and Sparta. As streets filled with corpses, socia... illness returned twice and Athens lost a third of...f Athens marked the beginning of the end of the Go...
Breaking Medicine News(10 mins):Health News:BlueChoice HealthPlan Ranks in Top Third of America's Best Health Plans 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 4Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 5Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 6Health News:ADHD Medications Don't Pose Cancer Risk 2Health News:Study of ancient and modern plagues finds common features 2Health News:Study of ancient and modern plagues finds common features 3Health News:Study of ancient and modern plagues finds common features 4
...ialists at UT Southwestern Medical Center have fou...d bacteria// that cause some of the most common ac...chers have looked for clues to an infection by tra...ing it. But that doesn’t always work because the b...
...outhern Indian state of Tamilnadu has launched a f...ients. The World Food Programme of the United Na...te government in running this scheme called Nutrip...n, Country Director for UNWFP and V.K.Subburaj, He...
...roposes to set up quality hospitals on the model o... Delhi, in Patna//, Raipur, Bhopal, Bhubaneshwar, ...stha Sureksha Yojna (PMSSY), Union Minister for He...doss has said. In a written reply to questions ra...
...d of India (AWBI) has started a pilot project in c...a new anti-rabies// oral bait vaccine that will be...and community dogs are being sterilized in India, ...mmunity dog population in the country is estimated...
Other Medicine News:Health News:‘Fingerprints’ to Track Common Infections in Childr 2Health News:‘Fingerprints’ to Track Common Infections in Childr 3
(Date:11/19/2008)...RANCISCO, Nov. 19 Posit Science Co...nce at the Society for Neuroscience,Annual Confer...ognitive,training may benefit Baby Boomers. The ... Program (TM) uses adaptive exercises that target ... designed to drive generalized,improvements in co...
(Date:11/19/2008)... , Study did not achieve statistical significa...FirstCall/ -- Pharmos Corporation (Nasdaq: PARS ...al trial of its topical NanoEmulsion (NE) drug del...thanolamine. , , The multi-center, randomiz...ated the safety and efficacy of the Company,s 3% D...
(Date:11/19/2008)...OCHELLE, N.Y., Nov. 19 Biotech sci...ogies to toxicology research to better understand ...of organ systems, reports Genetic Engineering &am...y interested in figuring out a new compound,s mech...tive toxicology technique, according to the Novemb...
(Date:11/19/2008)...gers $5 Million Payment from Roche- , , MON...ory Pharmaceuticals Corp. (Nasdaq: MEMY ) today ... for its Phase 2 trial of R3487/MEM 3454, its lead...impairment associated with schizophrenia (CIAS). ...se 2 trial, triggering a $5.0 million payment from...
Breaking Medicine Technology:New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2GEN Reports on the Trend Toward Predictive Toxicogenomics 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 3Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System 724 1Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System 724 2Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System 724 3Researchers discover new way to predict survival in older women with lung cancer 5267 1Researchers discover new way to predict survival in older women with lung cancer 5267 2Researchers discover new way to predict survival in older women with lung cancer 5267 3No racial differences seen in outcomes after liver transplantation 5265 1No racial differences seen in outcomes after liver transplantation 5265 2Potential new therapeutic molecular target to fight cancer 1076 1Potential new therapeutic molecular target to fight cancer 1076 2
...n Cancer Treatment,Decisions , SALT LAKE CITY, UT,...GN) (<a target="_blank" href=,"http://www.myriad.c...ented studies for a new technology that might be u...atic tumor, on Monday,April 16, 2007 at the annua...esearch (AACR) in Los Angeles, California. This wo...
..., Switzerland, April 19, 2007 /PRNewswire/ -- Debi...opharmaceutical,development specialist in oncology...nal results of a previous phase Ib, 15 day study,w...CV (hepatitis C,virus) co-infected patients. The d...he European Association for the Study of the,Liver...
Other Medicine Technology:Myriad Genetics Presents Tumor Origin Technology at AACR 2Myriad Genetics Presents Tumor Origin Technology at AACR 3Clinical Update - Debio 025 Cyclophilin Inhibitor for the Treatment,of HCV 2Clinical Update - Debio 025 Cyclophilin Inhibitor for the Treatment,of HCV 3Clinical Update - Debio 025 Cyclophilin Inhibitor for the Treatment,of HCV 4
DrDrugs®: Drug Guide for Physicians - now with over 760 Integrated Calculators - combines the most comprehensive, up-to-date and practical drug resource with built in drug dosing calculation too
Clinician's Pocket Drug Reference 2005 includes key elements of commonly used medications that are essential information for both the student and practicing physician.
The pharmaceutical subset of the authoritative 2005 edition of Title 21 of the Code of Federal Regulations (CFR) with proposals and final rules published in the Federal Register. Content is updated r
The Quality Module QS I evaluates and classifies the quality and quantity of centrifuged serum samples. The System analyses the tube, volume and cap and recognizes if a sample contains hemolytic, lip
Medicine Products: